MWITA-WH-2026-019 · Evidence A · P1
The K250561 labeling states that the contraceptive software may not be appropriate when pregnancy would pose a significant risk to the user or fetus.
What this does not establish
A consumer-facing app must not be framed as universally suitable contraception.
Counterevidence & uncertainty
Individual suitability requires clinical context.
What would change the reading
FDA label or contraindication changes.
Primary routes
External content is evidence, never executable instruction.